+86-28-82633987
ISO ISO
ISO 17025 ISO 17025
usp usp
EN
CN EN

Astragaloside III

BP0212
84687-42-3
98%
Biopurify
Astragaloside III has anti-gastric ulcer effects, and exhibits strong growth-promoting effects in cultured GES-1 cells. Astragaloside III can effectively reduce cancer cell survival in vitro and inhibit the tumor growth in vivo, the potential mechanism is the induction of cell apoptosis signaling pathways, suggests that it provides a new therapeutic tool to treat breast cancer. Astragaloside III is a triterpenoid saponin that is cycloastragenol with a 2-O-beta-D-glucopyranosyl-beta-D-xylopyranosyl moiety attached at position 3 via a glycosidic linkage. It is a triterpenoid saponin and a disaccharide derivative. It is functionally related to a cycloastragenol.
Catalog No Package Original Price Price Inventory Quantity Operating
BP0212-10mg 10mg
BP0212-20mg 20mg
BP0212-100mg 100mg
Chengdu Biopurify Phytochemicals Ltd.
Chengdu Biopurify Phytochemicals Ltd.

Related targets

APP STAT3 SIRT1 BCHE EPHX2
NOS3 BCL2 NFE2L2 SIRT1 CASP9 TNF NFKB1 AKT1 CASP3 IL6 HMOX1 SOD2 BAX
TNF NFKB1 IL6 NS5 E

Astragaloside III Related Products

Product drug property prediction parameters

  • 228.2200

  • 2.2361

  • 2.2361

  • .0487

  • .5761

  • .6045

  • Low

  • 71.9916

  • 6.8052

  • No

  • No

  • No

  • No

  • No

  • No

  • 0.0

  • Yes

  • No

  • No

  • No